S.F. Bellon
Impact in
- Toxicology top 10%
-
- Protein Degradation and Inhibitors
- Melanoma and MAPK Pathways
- Protein Kinase Regulation and GTPase Signaling
- Histone Deacetylase Inhibitors Research
- Cancer therapeutics and mechanisms
- Genomics and Chromatin Dynamics
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
Papers in
-
- Protein Degradation and Inhibitors 2
- Genomics and Chromatin Dynamics 1
- Ubiquitin and proteasome pathways 1
- Histone Deacetylase Inhibitors Research 1
- Advanced biosensing and bioanalysis techniques 1
- Cancer therapeutics and mechanisms 1
- Melanoma and MAPK Pathways 1
- Co-authors
- E. Megan Flynn (1 shared paper)Yong Tang (1 shared paper)Florence Poy (1 shared paper)Oscar W. Huang (1 shared paper)Mariano Oppikofer (1 shared paper)Andrea G. Cochran (1 shared paper)Keith P. Wilson (1 shared paper)Ted Fox (1 shared paper)
- Journals
- Structure (2 papers)Bioorganic & Medicinal Chemistry Letters (1 paper)PubMed (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
S.F. Bellon
3 papers receiving 363 citations
Peers
Comparison fields: 5 of 55
- Toxicology 20
- Molecular Biology 303
- Geriatrics and Gerontology 13
- Molecular Medicine 20
- Hematology 31
Countries citing papers authored by S.F. Bellon
This map shows the geographic impact of S.F. Bellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.F. Bellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.F. Bellon more than expected).
Fields of papers citing papers by S.F. Bellon
This network shows the impact of papers produced by S.F. Bellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.F. Bellon. The network helps show where S.F. Bellon may publish in the future.
Co-authors
The 25 scholars most cited alongside S.F. Bellon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 167 | |
| 2 | 1999 | 115 | |
| 3 | 2010 | 86 | |
| 4 | 2024 | 0 |
About S.F. Bellon
S.F. Bellon is a scholar working on Molecular Biology, Organic Chemistry, Toxicology, Infectious Diseases and Surgery, having authored 4 papers that have together received 368 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (2 papers), Genomics and Chromatin Dynamics (1 paper), Ubiquitin and proteasome pathways (1 paper), Bioactive Compounds and Antitumor Agents (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Advanced biosensing and bioanalysis techniques (1 paper), Cancer therapeutics and mechanisms (1 paper) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Toxicology (20 citations), Molecular Biology (303 citations), Geriatrics and Gerontology (13 citations), Molecular Medicine (20 citations) and Hematology (31 citations). S.F. Bellon has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include E. Megan Flynn, Yong Tang, Florence Poy, Oscar W. Huang, Mariano Oppikofer, Andrea G. Cochran, Keith P. Wilson, Ted Fox, Matthew J. Fitzgibbon and Trudy H. Grossman. Their work appears in journals such as Structure, Bioorganic & Medicinal Chemistry Letters and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.